CCR4 and breast cancer: The CCL17/C-C chemokine receptor 4 (CCR4) axis has been recently reported to induce the migration of hepatocellular carcinoma cells 17 and enhance epithelial-mesenchymal transition (EMT) in breast cancer via Akt signaling 18.